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Repeat after me: Replication in clinical neuroimaging is critical1. Background1
NeuroImage: Clinical is a journal that speciﬁcally deals with novel in-
sights relating to the use of neuroimaging to improve our understanding,
diagnosis and treatment of brain-related disorders. The numerous papers
already submitted have conﬁrmed that the importance of this enterprise
is recognised by the wider clinical community. We hope that the journal
will continue to growand come tobe a valuedoutlet for the best andmost
innovative developments in the neuroimaging of disease.
But the enterprise brings with it substantial tension. By encourag-
ing studies that report novel and exciting insights, there is a danger
that we may come to overlook a fundamental requirement to consol-
idate, scrutinise, test and, if necessary, rethink or discard these in-
sights. It is an embarrassing, though by no means unique, failing in
the neuroimaging ﬁeld that the quest for the new and exciting has
frequently over-shadowed the more humdrum side of science—the
need to replicate and re-evaluate. This failing is particularly indefen-
sible in clinical research where a key part of the goal must surely be
to translate the insights generated by initial experiments into credi-
ble, practically useful advances in patient management: prognostics,
diagnostics, treatment and monitoring.
To put things simply, if the frequently elegant experiments and
fascinating results of small scale clinically-orientated studies are ulti-
mately to inﬂuence clinical practice, they need to be replicated and
extended on a larger scale. At present, with most journals placing a
greater dividend on novelty, the incentive for researchers to do this
may seem too low to encourage the work. We would like to play
our own part in remedying this by actively encouraging the submission
of replications. We are therefore planning to create a new category of
paper (“Replication Study”). We recognise that there is enormous
complexity attached to replication within science (see, for example, the
November 2012 issue of Perspectives on Psychological Science) and we
acknowledge that, given the complexity of neuroimaging, we run the
risk of stiﬂing the overall effort if we are too prescriptive about what
authors of replication studies must do or not do and how they should or
should not state their claims. Rather, in launching this new category, we
put forward below a series of general considerations and questions for
the author wishing to submit a replication paper. These considerations
will be kept under review and we welcome comments.1.1. The science of replication: what papers do we want to publish?
We envision two general strategies for replication studies loosely
referred to as internal or external replication. Internal replication entails1 Summary: NeuroImage: Clinical proposes to initiate a new category of manuscript
reporting replication studies.
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(particularly in independent samples) with each experiment replicat-
ing and extending the preceding one. One example of this approach is
found in the Quarterly Journal of Experimental Psychology (pub Taylor
and Francis). This within-paper/study design is a particularly powerful
but somewhat under-used approach in neuroimaging. It would be
greatly welcome at NeuroImage: Clinical.
External replication is the more complicated and, perhaps, chal-
lenging enterprise of performing an experiment in a different labora-
tory, with new samples. These complications are further aggravated
in neuroimaging, where different scanners, data formats, image pro-
cessing pipelines and statistical inferences are adopted. Thus, a second
study is never identical to the ﬁrst, and so there is always a question
of what constitutes sufﬁcient agreement to constitute replication.
There is clearly a need for methodological innovations to facilitate com-
parisons across laboratories. In the meantime, these complexities do
not diminish the importance of attempting such external replications
and we hope that the knowledge that such work will be welcome at
NeuroImage: Clinical will encourage scientists to embark upon it. A
number of papers have outlined and developed taxonomies of replica-
tion (Burman et al., 2010; Drozar, 2010; Morrison et al., 2010) and
journals have used these structures to prescribe ways in which authors
might wish to set up, analyse and discuss their ﬁndings. To ensure
methodological consistency, some, for example, have emphasised the
need for close collaboration, or at the very least discussion between
the authors of the replication study and those of the original report.
While we do not wish to set a rigid guideline, we do ask that, in pre-
paring a replication paper for NeuroImage: Clinical, reviewers consider
one or more of the following general questions.
1. If a ﬁnding has been successfully replicated, in what ways does this
replication move the ﬁeld forward? Has the replication been
achieved in a larger group, making the ﬁnding more credible? Does
it generalise the ﬁnding? Does it add new insights that may assist
in drawing this ﬁnding towards having an impact on the clinic?
2. If the original ﬁnding has not been replicated, why not? Has the
original protocol been followed satisfactorily, i.e. to a sufﬁcient de-
gree that the non-replication calls the original ﬁnding or its inter-
pretation into question? Does the study go further and actually
offer an alternative explanation for the original ﬁnding, one that
is more fully tested and explored in the newer study? There are
several reasons why a ﬁnding may not replicate and not all of
these arise from an erroneous experimental procedure or conclu-
sion on the part of the original authors.
3. Are the authors of the replication independent of those who
presented the original ﬁnding? We suggest that a positive replica-
tion may carry more weight if it is conducted in a different lab by
different experimenters. (Whether a failure to replicate carries
248 Editorialmore weight if carried out by the original authors is perhaps an-
other matter).
In essence, we would ask authors considering such a submission to
think about whether the original paper/ﬁnding is of sufﬁcient weight
or importance that its replication or non-replication will itself be of
interest and impact and whether, if given further credence by its repli-
cation, it might have more immediate implications for clinical manage-
ment. Conversely, for a failure to replicate, the question is whether this
seriously challenges the paper's current or future impact on research
and practice? It would be helpful if authors submitting such studies
touched on these points in their cover letter.
2. The place of meta-analysis
Perhaps implicit in the above discussion is the view that a ﬁnding
is either “real” or not and that if it is, it should be reproducible. We
recognise that this dichotomy is a simplistic one: a ﬁnding is not nec-
essarily void if it doesn't replicate nor is it necessarily valid if it does.
Neuroimaging studies require complex statistical analyses at the level
of a single group, and even the single subject. The patterns emerging
across multiple studies are likely to require correspondingly complex
analyses for their validation. For this reason, meta-analyses of clinical
neuroimaging ﬁndings will play a large part in taking the ﬁeld for-
ward and in clarifying the nature and cause of variability, a variability
which, of course, may prove central to moving the ﬁeld towards pa-
tient management. After all, while we usually study groups, we diag-
nose and treat individuals.
3. A word on editorial process
3.1. Peer review
We are mindful that, when subjecting a replication study to the
peer review process, the authors of the original paper may be deemed
to have a conﬂict of interest. If the follow-up study reports a success-
ful replication, then they may be well-disposed towards it and, if it
does not, the opposite may be true. Yet, despite this possible conﬂict,
the authors of the original study may be in the best position to offer
comments and criticisms. We propose therefore that one of the authors
(preferably the senior or corresponding author) should be invited to
participate in the peer review process but that their view will be bal-
anced by two independent reviewers. That is, the aim will be to recruit
three rather than the usual two peer reviewers in order to provide as in-
formed and balanced a review process as possible.3.2. Publication
Should a replication study be considered suitable for publication,
we will aim, where appropriate, to provide an opportunity for the
authors of the original paper to write a brief response. Of course,
the publication of such a response would depend upon it being pro-
vided sufﬁciently promptly.
3.3. Final comments
Our hope is that you will join us in this endeavour to strengthen the
links between basic and clinical imaging science, and ultimately play
our part in allowing exciting, albeit fragile insights to translate into gen-
uine clinical improvements.
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